Author: Stefan Seyferth

Meet us at the DPhG Annual Meeting 2025 in Freiburg with the topic “Sustainability as a Challenge for the Pharmaceutical Sciences”. We will present in three presentations, a poster flash talk and several poster contributions our latest research in concepts for green and sustainable drug formulat...

We are happy to welcome the PETRS Network, an associated member of APV Mainz (APV Mainz: PETRS) on 23 September 2025 at the Pharmaceutical Technology and Biopharmacy  to present our work and the FAU and to exchange ideas. Founded in 2020, the PETRS (Pharmaceutical Engineering and Technology...

Im Rahmen wer neuen Weiterbildung zum Fachapotheker "Pädiatrische Pharmazie" der Landesapothekerkammern werden die Referenten Dr. Stefan Seyferth und Dr. Andreas Ziegler angehende Fachapotheker erstmalig am 19.09. / 20.09.2025 zu dem neuen (Praxis-)Seminar "Kindgerechte Arzneiformen und pädiatris...

Welcome XNA Pharma  at FAU to learn more about our process of formulating and analyzing oligonucleotide lipid nanoparticles! Our particles take the next step to transfer in the TEL-Drug Delivery project  We look forward to more collaborations with XNA Pharma on TEL-Drug Delivery and more future proj...

The  Frankfurt Foundation Quality of Medicines (FFQM) honored the extraordinary achievements of Professor Gordon L. Amidon (University of Michigan, Ann Arbor, USA) in the field of pharmaceutical sciences and his outstanding contributions to improving the quality and efficacy of medicines. The awa...

The FAU welcomes the partners of the SMARTIES project funded by ZIM/BMWK (16KN070964) for the status meeting at 26 and 27 May 2025 in Erlangen to exchange actual data, create new ideas and strenghthen the network.

On 23 May 2025 at 10.15 am Vincent Lau from the Helmholtz Institute for RNA-based Infection Research in Würzburg will join us for a presentation in our DFG project „Development of a Selective Antimicrobial Cystic Fibrosis Therapy Approach". DFG Fördernummer: Fi 899/11-1 (529859253).